Beijing Tiantan Biological Products Corporation LimitedSSE: 600161

(600161)"BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD."Report for Q3 2026

· Issued by Beijing Tiantan Biological Products Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Stock code 600161 · · 16 pages · Chinese

Summary by 6ix AI

The report indicates a decline in revenue and net profit compared to the same period last year, attributed to changes in tax policy and product pricing. The total assets of the company have increased slightly, while the equity attributable to shareholders has also seen a modest rise. The report emphasizes the accuracy and completeness of the financial information provided, with no audit conducted for this quarter.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Beijing Tiantan Biological Products Corporation Limited on 6ix

Earlier from Beijing Tiantan Biological Products

Later from Beijing Tiantan Biological Products

All Beijing Tiantan Biological Products news releases